Skip to main content
. 2019 Jul 15;11(7):987. doi: 10.3390/cancers11070987

Figure 1.

Figure 1

(A) Liver MRI (arterial phase) showing a 4-cm HCC (arrows) in segment VI in a 71-year-old cirrhotic patient. (B) MRI (arterial phase) performed three months after a super-selective DEB-TACE session (using 10 mg idarubicin loaded in 75-µm TANDEM beads administered through the segment VI artery) showing complete response (star) upon mRECIST, with dilatation of the segmental bile duct (arrow).